EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

β-Sitosterol Exerts Modest Anti-Androgenic Effects in Experimental Benign Prostatic Hyperplasia: A Comparative Study with Dutasteride

Mădălina Buț, Amelia Tero-Vescan, Camil-Eugen Vari, Bianca-Eugenia Ősz, Amalia Pușcaș, George Jîtcă, László-István Bába, Andreea-Raluca Cozac-Szőke, Mădălina Nistor, Ximena Maria Muresan

International Journal of Molecular Sciences · 19.11.2026 · 27 (22) · 10403

DOI: 10.3390/ijms272210403 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 19.11.2026. Verfasst von Mădălina Buț und 9 weiteren Autor:innen. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Benign prostatic hyperplasia (BPH) is an age-related condition strongly associated with androgen signaling, chronic inflammation, and dysregulated apoptosis. This study evaluated the antiandrogenic, anti-inflammatory, and proapoptotic effects of β-sitosterol in a testosterone-induced BPH model in orchiectomized Wistar rats. BPH was induced by testosterone propionate (TP) administration. Animals were treated with β-sitosterol, dutasteride, or their combination. Prostate weight, the prostate index, plasma testosterone (TST) and dihydrotestosterone (DHT), and their ratio, the levels of interleukin-1β (IL-1β) and interleukin-6 (IL-6), histopathological changes, and the ratio of BCL2-associated X protein (Bax) to B-cell lymphoma 2 protein (Bcl-2) were assessed. β-Sitosterol significantly increased the TST/DHT ratio compared with the untreated BPH group. However, this change was not accompanied by significant reductions in prostate weight or prostate index. Furthermore, its effects on inflammatory cytokines and apoptosis-related markers did not reach statistical significance following monotherapy. These findings support the further investigation of β-sitosterol as a potential complementary approach to BPH management, rather than as an equivalent alternative to established pharmacological treatments, including through optimized formulations or combinations with other bioactive compounds.

Zitieren

APA

Buț, M., Tero-Vescan, A., Vari, C., Ősz, B., Pușcaș, A., Jîtcă, G., Bába, L., Cozac-Szőke, A., Nistor, M., & Muresan, X. M. (2026). β-Sitosterol Exerts Modest Anti-Androgenic Effects in Experimental Benign Prostatic Hyperplasia: A Comparative Study with Dutasteride. International Journal of Molecular Sciences, 27(22), 10403. https://doi.org/10.3390/ijms272210403

Vancouver

Buț M, Tero-Vescan A, Vari C, Ősz B, Pușcaș A, Jîtcă G, et al. β-Sitosterol Exerts Modest Anti-Androgenic Effects in Experimental Benign Prostatic Hyperplasia: A Comparative Study with Dutasteride. International Journal of Molecular Sciences. 2026;27(22):10403. doi:10.3390/ijms272210403

BibTeX
@article{Bu2026,
  author = {Buț, Mădălina and Tero-Vescan, Amelia and Vari, Camil-Eugen and Ősz, Bianca-Eugenia and Pușcaș, Amalia and Jîtcă, George and Bába, László-István and Cozac-Szőke, Andreea-Raluca and Nistor, Mădălina and Muresan, Ximena Maria},
  title = {β-Sitosterol Exerts Modest Anti-Androgenic Effects in Experimental Benign Prostatic Hyperplasia: A Comparative Study with Dutasteride},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {22},
  pages = {10403},
  doi = {10.3390/ijms272210403}
}
Kostenlos starten →